3 research outputs found

    Protease inhibitor resistance analysis in the MONARK trial comparing first-line lopinavir-ritonavir monotherapy to lopinavir-ritonavir plus zidovudine and lamivudine triple therapy

    No full text
    Collaboratore della suddetta ricerca in quanto membro del MONARK Study Grou

    Efficacy of Retreatment After Failed Direct-acting Antiviral Therapy in Patients With HCV Genotype 1–3 Infections

    No full text
    corecore